Page last updated: 2024-08-18

tetraethylenepentamine and B16 Melanoma

tetraethylenepentamine has been researched along with B16 Melanoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, H; Asai, T; Dewa, T; Kato, H; Koide, H; Maeda, N; Nango, M; Oku, N; Yokota, M; Yonenaga, N1
Asai, T; Dewa, T; Kenjo, E; Nango, M; Oku, N; Shimizu, K; Tsuruta, A; Yonenaga, N1
Ando, H; Asai, T; Harada, N; Hatanaka, K; Koide, H; Oku, N; Tsukada, H; Tsuzuku, T; Yonenaga, N1
Ando, H; Asai, T; Dewa, T; Hatanaka, K; Ishii, T; Kenjo, E; Nango, M; Oku, N; Shimizu, K; Tsukada, H; Urita, Y; Yonenaga, N1

Reviews

1 review(s) available for tetraethylenepentamine and B16 Melanoma

ArticleYear
[In vivo imaging of liposomal small interfering RNA (siRNA) trafficking by positron emission tomography].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:12

    Topics: Animals; Drug Delivery Systems; Drug Discovery; Ethylenediamines; Fluorine Radioisotopes; Humans; Liposomes; Lung Neoplasms; Melanoma, Experimental; Molecular Imaging; Polyethylene Glycols; Positron-Emission Tomography; Radiopharmaceuticals; RNA, Small Interfering; Tissue Distribution

2012

Other Studies

3 other study(ies) available for tetraethylenepentamine and B16 Melanoma

ArticleYear
Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin.
    Nanomedicine : nanotechnology, biology, and medicine, 2015, Volume: 11, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cell Proliferation; Ethylenediamines; Liposomes; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Phosphatidylethanolamines; Phosphorylation; Polyethylene Glycols; PTEN Phosphohydrolase; RNA, Small Interfering; TOR Serine-Threonine Kinases

2015
RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Jun-10, Volume: 160, Issue:2

    Topics: Animals; Cations; Cell Line, Tumor; Drug Carriers; Ethylenediamines; Genetic Therapy; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Organophosphates; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays

2012
Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:2

    Topics: Animals; Cell Proliferation; Ethylenediamines; Liposomes; Lung; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organophosphates; Peptides, Cyclic; Polyethylene Glycols; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Salivary alpha-Amylases; Vascular Endothelial Growth Factor A

2013